Acta Med. 2025, 68: 14-20
https://doi.org/10.14712/18059694.2025.13
Clinical Evaluation of Oxidized Cellulose Powder and Endoscopic Applicator in Multicenter Trial
References
1. O, Cimbanassi S, Bellanova G, et al. A systematic review on the use of topical hemostats in trauma and emergency surgery. BMC Surg. 2018 Aug 29; 18(1): 68.
<https://doi.org/10.1186/s12893-018-0398-z>
<PubMed>
2. KM, Spazierer D, Urban MD, Lin L, Redl H, Goppelt A. Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents. Eur Surg. 2013; 45(4): 213–20.
<https://doi.org/10.1007/s10353-013-0222-z>
<PubMed>
3. VK, Lattes R. Oxidized cellulose-absorbable gauze (cellulosic acid). JAMA. 1945; 129: 798–801.
<https://doi.org/10.1001/jama.1945.02860460022006>
4. S, Zahedi Z, Parand S, Karimi M. An experience of using Traumastem P in control of spontaneous nose bleeding in patients with inherited bleeding disorders in southern Iran. Haemophilia. 2014 Jan; 20(1): e79–80.
<https://doi.org/10.1111/hae.12270>
5. P, Másová L, Suttnar J, et al. The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose. J Biomed Mater Res A. 2007 Aug; 82(2): 274–80.
<https://doi.org/10.1002/jbm.a.31060>
6. MA, Yang Y, Cherry GW. Effect of Traumacel P on the growth of human dermal fibroblasts in vitro. J Wound Care. 2002 Apr; 11(4): 149–54.
<https://doi.org/10.12968/jowc.2002.11.4.26392>
7. D, Wilson J, Poore S, Cherry G, Ryan T. Can traumacel be used in the treatment of chronic wounds? J Wound Care. 2000 Sep; 9(8): 393–6.
<https://doi.org/10.12968/jowc.2000.9.8.26280>
8. P, Sívková V, Votava P. Comparison of Efficacy and Safety of Non-Regenerated and Regenerated Oxidized Cellulose Based Fibrous Haemostats. Acta Med (Hradec Kralove). 2022; 65(2): 53–8.
<https://doi.org/10.14712/18059694.2022.18>
9. N, de Jonge E, Kocharian R, Ilie B, Barnett E, Berrevoet F. Safety and Hemostatic Effectiveness of SURGICEL® Powder in Mild and Moderate Intraoperative Bleeding. Clin Appl Thromb Hemost. 2023; 29: 1–10.
<https://doi.org/10.1177/10760296231190376>
<PubMed>
10. RK, Baumgartner B, Mantei JR, et al. Hemostatic Comparison of a Polysaccharide Powder and a Gelatin Powder. J Invest Surg. 2019 Aug; 32(5): 393–401.
<https://doi.org/10.1080/08941939.2017.1423421>
11. C, Fu D, Wang F, et al. A randomized controlled trial to compare the efficacy of regenerated and non-regenerated oxidized cellulose gauze for the secondary treatment of local bleeding in patients undergoing hepatic resection. Ann Surg Treat Res. 2021 Apr; 100(4): 193–9.
<https://doi.org/10.4174/astr.2021.100.4.193>
<PubMed>
12. MH, Wang AY, Clymer JW, Hutchinson RW, Kocharian R. An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models. Med Devices (Auckl). 2017 Nov; 10: 273–9.
13. Y, Kim EJ, Lee A, et al. In vivo study for the hemostatic efficacy and foreign body reaction of a new powder-type polysaccharide hemostatic agent. Ann Surg Treat Res. 2022 Feb; 102(2): 65–72.
<https://doi.org/10.4174/astr.2022.102.2.65>
<PubMed>
14. X, Han Z, Zhang G, Zhang S, Li Z, Tian H. Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty. Clin Appl Thromb Hemost. 2024 Jan–Dec; 30: 1–7.
15. KH, Lee JH, Chung YS, Chun YS, Park HK, Kim YY. The efficacy of oxidized regenerated cellulose (SurgiGuard®) in breast cancer patients who undergo total mastectomy with node surgery: A prospective randomized study in 94 patients. PLoS One. 2022 May 27; 17(5): e0267694.
<https://doi.org/10.1371/journal.pone.0267694>
<PubMed>
16. Y, Imamura H, Shirakawa Y, Takagi H, Okazaki K. Hypersensitive Reaction of Oxidized Regenerated Cellulose Powder in Total Knee Arthroplasty. Cureus. 2024 Apr; 16(4): e59097.
17. D, Pijuan L, Curull V, Sánchez-Font A. A foreign body reaction to Surgicel® in a lymph node diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Med. 2017 Jan–Mar; 12(1): 55–6.
